Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Cerenis Therapeutics SA

September 3, 2014
Cerenis appoints Dr. Richard C. Pasternak as Chairman
Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-β HDL mimetic for the treatment of cardiovascular disease, announced today the appointment of Richard C. Pasternak, MD, as Chairman of the Board of Directors. More

March 15, 2011
Cerenis initiates Phase 2 study of lead product candidate, CER-001, in patients with acute ...
Cerenis initiates Phase 2 study of lead product candidate, CER-001, in patients with acute coronary syndrome More

October 21, 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Cerenis Therapeutics, a biopharmaceutical company specializing in the research and development of novel therapies based on HDL to treat cardiovascular and other metabolic diseases, announced today it has raised a further 10 million in a second close of its Series C financing. More

May 18, 2010
Cerenis reports positive results for Phase 1 study of CER-001, an HDL mimetic ...
Cerenis reports positive results for Phase 1 study of CER-001, an HDL mimetic, for the treatment of cardiovascular disease. More

September 2, 2009
Cerenis Therapeutics adds three pharmaceutical industry veterans to its teams
Cerenis Therapeutics adds three pharmaceutical industry veterans to its clinical, regulatory affairs and business development teams. More

May 15, 2008
Cerenis Therapeutics announces successful completion of phase I clinical trial of CER-002
Cerenis Therapeutics announces successful completion of phase I clinical trial of CER-002 for treatment of cardiovascular disease More

January 23, 2008
Robert A. Scott, M.D., appointed Chief Medical Officer of Cerenis Therapeutics
Cerenis Therapeutics SA, a privately held pharmaceutical company developing HDL compounds for the treatment of cardiovascular and metabolic diseases, today announced the appointment of Rob Scott, M.D., as the company's chief medical officer. More

March 23, 2007
Cerenis Therapeutics announces formation of Scientific Advisory Board
Cerenis Therapeutics announces formation of Scientific Advisory Board and expansion of Board of Directors
H. Bryan Brewer, Jr., M.D., John J.P. Kastelein, M.D., Ph.D., Jean-Claude Tardif, M.D., and Mark Skaletsky bring a broad range of HDL and cardiovascular experience to Cerenis More

Data


27,871
Tech investments
From our Online Data Service
17,963
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 11
Kalysis
the world's most advanced bluetooth key for digital tachographs

Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.